Is Hexarelin safe?
Limited EvidenceSide effects, risks, and safety considerations based on available research.
Research status
Hexarelin has very limited human safety data. Most information comes from animal studies, in vitro research, or anecdotal reports. This means the true risk profile in humans is largely unknown.
Known concerns & side effects
- ⚠elevates cortisol and prolactin more than Ipamorelin — meaningful drawback for regular use
- ⚠tachyphylaxis: GH response diminishes within 4 weeks of continuous use
- ⚠no FDA approval; research chemical only
- ⚠long-term human safety data absent
- ⚠not a licensed pharmaceutical in most countries
Use caution with
See all 2 studies on the full Hexarelin profile.
Frequently asked questions
How does Hexarelin compare to Ipamorelin?
Hexarelin produces larger GH pulses than Ipamorelin at equivalent doses, but significantly elevates cortisol and prolactin — something Ipamorelin avoids entirely. For most users seeking GH stimulation with fewer side effects, Ipamorelin is preferred. Hexarelin's main ongoing research interest is its cardiac GHSR-1a activation, which occurs independently of GH.
Why does Hexarelin stop working after a few weeks?
Hexarelin causes rapid tachyphylaxis — GHSR-1a receptors desensitize faster than with other GHRPs such as GHRP-2. Continuous daily use leads to blunted GH responses within 3–4 weeks. Cycling off for several weeks allows receptor sensitivity to recover.
Full Hexarelin Profile
Evidence, timeline, products & more
Take the Peptide Quiz
Get personalized recommendations
Last updated: 2026-06-10
Medical Disclaimer
The information on this site is for educational and informational purposes only. It is not intended as medical advice and should not be used to diagnose, treat, or prevent any condition. Always consult with a qualified healthcare professional before starting any new supplement, peptide, or treatment protocol.